These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15382064)

  • 1. HLA-DRB alleles are differentially expressed by tumor cells in breast carcinoma.
    Oldford SA; Robb JD; Watson PH; Drover S
    Int J Cancer; 2004 Nov; 112(3):399-406. PubMed ID: 15382064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of HLA-DR expression and T-lymphocyte infiltration in osteosarcoma.
    Trieb K; Lechleitner T; Lang S; Windhager R; Kotz R; Dirnhofer S
    Pathol Res Pract; 1998; 194(10):679-84. PubMed ID: 9820863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor HLA-DR expression linked to early intrahepatic recurrence of hepatocellular carcinoma.
    Matoba K; Iizuka N; Gondo T; Ishihara T; Yamada-Okabe H; Tamesa T; Takemoto N; Hashimoto K; Sakamoto K; Miyamoto T; Uchimura S; Hamamoto Y; Oka M
    Int J Cancer; 2005 Jun; 115(2):231-40. PubMed ID: 15688398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical analysis of tumor-infiltrating lymphocytes in breast carcinoma: relation to prognostic variables.
    Helal TE; Ibrahim EA; Alloub AI
    Indian J Pathol Microbiol; 2013; 56(2):89-93. PubMed ID: 24056641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance.
    Hilders CG; Munoz IM; Nooyen Y; Fleuren GJ
    Gynecol Oncol; 1995 Jun; 57(3):366-75. PubMed ID: 7774840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cell expression of HLA-DM associates with a Th1 profile and predicts improved survival in breast carcinoma patients.
    Oldford SA; Robb JD; Codner D; Gadag V; Watson PH; Drover S
    Int Immunol; 2006 Nov; 18(11):1591-602. PubMed ID: 16987935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of HLA class II antigens and tumor infiltrating mononuclear cells in renal cell carcinoma: correlation with clinical and histopathological data.
    Brasanac D; Marković-Lipkovski J; Hadzi-Djokić J; Müller GA; Müller CA
    Neoplasma; 1999; 46(3):173-8. PubMed ID: 10613593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
    Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
    Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC class II antigen-associated invariant chain on renal cell cancer may contribute to the anti-tumor immune response of the host.
    Saito T; Kimura M; Kawasaki T; Sato S; Tomita Y
    Cancer Lett; 1997 May; 115(1):121-7. PubMed ID: 9097987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
    Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
    Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discordant expression of HLA class II-associated co-chaperones and HLA-DRB alleles in cultured fibroblast-like synoviocytes.
    Spurrell DR; Oldford SA; Frost T; Larsen B; Codner D; Edgecombe A; Drover S
    Hum Immunol; 2004 Dec; 65(12):1516-29. PubMed ID: 15603880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA class I expression on human ovarian carcinoma cells correlates with T-cell infiltration in vivo and T-cell expansion in vitro in low concentrations of recombinant interleukin-2.
    Kooi S; Zhang HZ; Patenia R; Edwards CL; Platsoucas CD; Freedman RS
    Cell Immunol; 1996 Dec; 174(2):116-28. PubMed ID: 8954611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA class II antigen expression in human papillomavirus-associated cervical cancer.
    Glew SS; Duggan-Keen M; Cabrera T; Stern PL
    Cancer Res; 1992 Jul; 52(14):4009-16. PubMed ID: 1377602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of T-cell infiltrates, expression of beta 2-microglobulin and HLA-DR antigens in breast carcinoma.
    Lucin K; Iternicka Z; Jonjić N
    Pathol Res Pract; 1994 Dec; 190(12):1134-40. PubMed ID: 7792204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between HLA-expression and infiltration of immune cells in cervical carcinoma.
    Hilders CG; Houbiers JG; van Ravenswaay Claasen HH; Veldhuizen RW; Fleuren GJ
    Lab Invest; 1993 Dec; 69(6):651-9. PubMed ID: 8264228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicators.
    Georgiannos SN; Renaut A; Goode AW; Sheaff M
    Surgery; 2003 Nov; 134(5):827-34. PubMed ID: 14639362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast.
    Rathore AS; Kumar S; Konwar R; Makker A; Negi MP; Goel MM
    Indian J Med Res; 2014 Sep; 140(3):361-9. PubMed ID: 25366203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-co-ordinate expression of HLA-DR antigens and invariant chain.
    Momburg F; Möller P
    Immunology; 1988 Mar; 63(3):551-3. PubMed ID: 3280476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA expression in basal cell carcinomas.
    Garcia-Plata D; Mozos E; Sierra MA; Peña J; Solana R
    Invasion Metastasis; 1991; 11(3):166-73. PubMed ID: 1834604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.
    Valli A; Sette A; Kappos L; Oseroff C; Sidney J; Miescher G; Hochberger M; Albert ED; Adorini L
    J Clin Invest; 1993 Feb; 91(2):616-28. PubMed ID: 7679413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.